GLP2 - TRZ 60mg

PeptiQ Labs provides high-purity Tirzepatide, a synthetic peptide analog targeting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This 60mg formulation is designed for researchers studying metabolic pathways, insulin signaling, weight management mechanisms, and related endocrinology research. Quality Assurance Our Tirzepatide is synthesized under strict laboratory standards. Each batch is validated via High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥98%, offering consistent and reliable results for metabolic, peptide, and pharmacological studies. Key Specifications:

• Active Substance: Tirzepatide
• Concentration: 60mg per vial
• Purity: ≥98% (HPLC verified)
• Form: Lyophilized (Freeze-dried) Powder

Manufacturer: PeptiQ Labs Storage & Handling:

• Lyophilized: Store vials at -4°F (-20°C) for optimal stability.
• Reconstitution: Reconstitute with bacteriostatic water or sterile saline.
• Post-Reconstitution: The solution is sensitive to light and temperature. Keep refrigerated and use immediately or aliquot and freeze to avoid repeated freeze-thaw cycles.

IMPORTANT RESEARCH DISCLAIMER: FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is intended strictly for in-vitro research and analytical applications. It is not approved by the FDA or any other regulatory body for human or veterinary therapeutic use. It is not intended to diagnose, treat, or prevent any disease or condition. Purchase is restricted to qualified researchers and licensed professionals.